With diseases like COVID-19, monkeypox, and Ebola, the last few years have highlighted the importance of preparedness and response to global infectious diseases. This includes R&D focused on developing products against current or future global health threats and ongoing R&D efforts aim to expand and improve on these vaccines and therapeutics, developing candidates on different platforms and with better, longer-lasting, or expanded efficacy. Such products can be used during health crises in the US or abroad, to protect and treat travelers, address the burden of infectious diseases that affect many people around the world, and protect against future disease threats in the event of their global spread.